Evidence map›Paper›PMID 37019617›Full record

ArticleJournal of medical genetics2023

Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort.

Ulrik Kristoffer Stoltze, Mathis Hildonen, Thomas Van Overeem Hansen, Jon Foss-Skiftesvik, Anna Byrjalsen, Malene Lundsgaard, Laura Pignata, Karen Grønskov, Zeynep Tumer, Kjeld Schmiegelow and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Wilms tumor characteristics in children with heterozygous germline DIS3L2 variants.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Ulrik Kristoffer StoltzeDepartment of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark ulrik.kristoffer.stoltze@regionh.dk.ORCID 0000-0001-5862-3292
Mathis HildonenDepartment of Genetics, Kennedy Center-National Research Center on Rare Genetic Diseases, Glostrup, Denmark.
Thomas Van Overeem HansenDepartment of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark.
Jon Foss-SkiftesvikDepartment of Neurosurgery, Rigshospitalet, Copenhagen, Denmark.
Anna ByrjalsenDepartment of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark.
Malene LundsgaardDepartment of Clinical Genetics, Aalborg University Hospital, Aalborg, North Denmark Region, Denmark.
Laura PignataDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, Università Degli Studi Della Campania "Luigi Vanvitelli", Caserta, Italy.
Karen GrønskovDepartment of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark.
Zeynep TumerApplied Human Molecular Genetics, Kennedy Center, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark.
Kjeld SchmiegelowPediatric Oncology Laboratory, Rigshospitalet, Kobenhavn, Denmark.
Jesper Sune BrokDepartment of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark.
Karin A W WadtDepartment of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark.
Rigshospitalet · DKCopenhagen University Hospital · DKAalborg University Hospital · DKKennedy Center · DKUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudies suggest that Wilms tumours (WT) are caused by underlying genetic (5%-10%) and epigenetic (2%-29%) mechanisms, yet studies covering both aspects are sparse.

methodsWe performed prospective whole-genome sequencing of germline DNA in Danish children diagnosed with WT from 2016 to 2021, and linked genotypes to deep phenotypes.

resultsOf 24 patients (58% female), 3 (13%, all female) harboured pathogenic germline variants in WT risk genes (

conclusionWe find that most females (57%) and 33% of all patients with WT had either a genetic or another indicator of WT predisposition. This emphasises the need for scrutiny when diagnosing patients with WT, as early detection of underlying predisposition may impact treatment, follow-up and genetic counselling.

Indexed as

Beckwith-Wiedemann SyndromeKidney NeoplasmsWilms TumorDisease SusceptibilityDNA MethylationF-Box-WD Repeat-Containing Protein 7FemaleFetal MacrosomiaGenomic ImprintingGenotypeGerm CellsHumansMaleF-Box-WD Repeat-Containing Protein 7biological evolutionDNA methylationgeneticsmedical oncologypediatrics

Identifiers

PMID37019617
PMCPMC10447365
OpenAlexW4362636280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.